A new way to remove leftover asthma medicine from the mouth
Treatments studied
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests a method to clean medicine residue from your mouth after using a common asthma inhaler (fluticasone propionate). It may help prevent side effects like oral thrush. The study includes healthy adults and those with asthma.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You are a healthy adult or have asthma
- You can stop using inhaled corticosteroids (like Flovent, Advair) for 24 hours, and nasal sprays containing them for 12 hours, before study visits
- You have not used steroid eye drops or skin creams in the last 4 weeks
- You are not allergic to fluticasone, olives, olive oil, or oxymetazoline (a nasal decongestant)
- You do not currently smoke or vape, and are not pregnant or trying to become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new combination inhaler (fluticasone propionate and albuterol) for people with asthma age 12 and older. It helps see if this inhaler works better than a placebo in controlling asthma symptoms and preventing attacks.
This trial uses special imaging to look at how air moves through your lungs. It may help doctors understand asthma better and could lead to better treatments.
This trial compares the safety of two different propellants (the gases that push medicine out of inhalers) in people with well-controlled asthma. Researchers want to ensure both propellants are safe to use in asthma inhalers.
This study tests if using a small smart device with your Trimbow inhaler helps you use it correctly and take it as prescribed. It is for people with asthma who already use Trimbow.
This study compares two versions of the common asthma rescue inhaler (salbutamol/albuterol) that use different propellants (the gas that pushes the medicine out). The goal is to see if the new propellant works as well as the current one. If you have mild asthma and are on a stable treatment plan, you may be able to join.
This study tests different doses of a new medicine (PF-08103402) to see how well it is tolerated and how it works in both healthy adults and adults with mild to moderate asthma. It helps researchers find the right dose for future studies.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.